← Eichor
Condition: Alpha 1 Antitrypsin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Alpha 1 Antitrypsin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1 · 6 location(s) · AIRNA Corporation · NCT07431112Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"
Phase 3 · 9 location(s) · Kamada, Ltd. · NCT04204252Czech AATD Registry
Phase N/A · 1 location(s) · Thomayer University Hospital · NCT05178277PiMZ Longitudinal Cohort (PiMZ Logic)
Phase N/A · 5 location(s) · Columbia University · NCT06505603Gene Therapy for Alpha 1- Antitrypsin Deficiency
Phase 1 · 1 location(s) · Weill Medical College of Cornell University · NCT06996756Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction
Phase N/A · 1 location(s) · Muğla Sıtkı Koçman University · NCT07152834Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
Phase N/A · 1 location(s) · University of Florida · NCT01851642Alpha-1 Research Registry
Phase N/A · 1 location(s) · Alpha-1 Foundation · NCT04157049An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild
Phase 3 · 41 location(s) · Takeda · NCT06165341Role of Genetic Factors in the Development of Lung Disease
Phase N/A · 2 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001532The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
Phase N/A · 1 location(s) · University of Florida · NCT00500123A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compar
Phase 3 · 22 location(s) · Grifols Therapeutics LLC · NCT07555483Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT07135427A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1/Phase 2 · 11 location(s) · Beam Therapeutics Inc. · NCT06389877Zemaira Eosinophilic Esophagitis Pilot Study
Phase 2 · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05485155A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems
Phase N/A · 8 location(s) · Takeda · NCT06512454A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
Phase 1 · 3 location(s) · Krystal Biotech, Inc. · NCT06049082Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosi
Phase 3 · 89 location(s) · Takeda · NCT05677971Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Seconda
Phase N/A · 4 location(s) · University Hospital, Bordeaux · NCT07715617A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1/Phase 2 · 4 location(s) · Tessera Therapeutics, Inc. · NCT07227207
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.